Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
232.7 EUR | -1.90% | -4.24% | -19.03% |
06-28 | Would you like some more inflation? | |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
Evolution of the average Target Price on Genmab A/S
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Genmab A/S
Truist Securities | |
alphavalue | Anas Patel |
BMO Capital | |
RBC Capital Markets | |
HC Wainwright | |
Morgan Stanley | |
BTIG | |
SVB Securities LLC | |
William Blair & Co. | |
DNB Markets | |
Credit Suisse | |
Bryan, Garnier & Co. | |
Cowen | |
SVB Leerink | |
Guggenheim | |
Berenberg Bank | |
Jefferies & Co. | |
Deutsche Bank Securities | |
Danske Bank Group |
EPS Revisions
- Stock Market
- Equities
- GMAB Stock
- GE9 Stock
- Consensus Genmab A/S